| 1 |
33135264 | Sunitinib decreases the expression of KRT6A and SERPINB1 in 3D human epidermal models. | 2021 Mar |
3 |
| 2 |
33887553 | Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor. | 2021 Jul |
1 |
| 3 |
30821250 | Synergic effects of inhibition of glycolysis and multikinase receptor signalling on proliferation and migration of endothelial cells. | 2019 Mar |
1 |
| 4 |
30200486 | Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis. | 2018 Sep 1 |
1 |
| 5 |
28413468 | Antitumor effect of sunitinib in human prostate cancer cells functions via autophagy. | 2017 Apr |
2 |
| 6 |
27990160 | The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas. | 2016 |
1 |
| 7 |
25893276 | Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells. | 2015 Aug 1 |
1 |
| 8 |
23812726 | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. | 2013 Dec |
1 |
| 9 |
23969186 | Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1. | 2013 Sep |
3 |
| 10 |
21455800 | Concurrent and sequential administration of sunitinib malate and docetaxel in human non-small cell lung cancer cells and xenografts. | 2012 Jun |
1 |
| 11 |
22344606 | Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation. | 2012 May |
2 |
| 12 |
22442268 | Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines. | 2012 Jun |
2 |
| 13 |
21693010 | Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3. | 2011 Jun 21 |
1 |
| 14 |
20629553 | Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary thyroid cancer. | 2010 Sep |
1 |